Myasthenia gravis history and symptoms
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
History: Female Gender, african/Americans race, evidence of coexisting autoimmune diseases, a positive history of: Heavy eyelids and double vision , eye movement problems
Photophobia , facial weakness, tongue weakness, chewing and swallowing problems, respiratory problems, limbs muscles weakness, Fatigue and urinary incontinency.symptoms: Ptosis and diplopia, gaze paralysis, photophobia, facial weakness, orbicularis oculi weakness, tongue weakness (chewing problems and dysphagia), respiratory problems, limbs muscles weakness, fatigue and pelvic floor weakness.
History and Symptoms
History and Symptoms
History
- The important points in the history of a patient suspected for MG are:
- Age and Gender: The age of onset in Myasthenia gravis follows a bimodal distribution. The early type (before age of 50) is female predominant and the late type (after age of 60) is male predominant. Between the age of 50-60 there is no significant different between male and female.[1]
- Race: Some studies demonstrated that the incidence, prevalence and the severity of this disease is higher in African/Americans.[2][3]
- Evidence of coexisting autoimmune diseases[4]
- A positive history of:
- The importatnt point which we should keep in mind is that The hallmark of myasthenia gravis is Fluctuating weakness of specific muscles in limbs, bulbar, ocular and respiratory system which get worse with activity or using the muscle.[20][21][22]
Common symptoms
- The hallmark of myasthenia gravis is Fluctuating weakness of specific muscles in limbs, bulbar, ocular and respiratory system which get worse with activity or using the muscle.[20][21][22]
- Symptoms of myasthenia gravis include:
- ptosis and diplopia
- Gaze paralysis
- The ocular muscle weakness in MG can cause gaze paralysis and even mimic internuclear ophthalmoplegia or midline brain lesions.[6]
- Photophobia
- A lot of patients with myasthenia gravis complain that bright light bothers them and can even worsen the weakness of their eye muscles. Since this symptom is seen even in untreated patients, itβs not a complication of anticholinesterases treatment.[7]
- Facial weakness
- Orbicularis oculi weakness
- If we try to keep the upper eyelid of a MG patient open, they cannot close it against our force because of the weakness of orbicularis oculi muscle.[23]
- tongue weakness, chewing problems and dysphagia
- The muscles of the tongue will become weak in MG patients especially after long speech. This can lead to unintelligible speech and dysphasia. Difficulty in swallowing can cause choking and nasal regurgitation. Furthermore the weakness of mastication muscles will cause chewing problem and can lead to weight loss.[9][10]
- Respiratory problems
- Limbs muscles weakness
- Because the distal part of the limbs is warmer, they have less reserve of Ach and they will show more weakness.[13]
- The proximal muscles of upper extremities show weakness during hair brushing or dressing.[14]
- The proximal muscles of lower extremities show weakness during walking up stair[15]
- The distal muscle of limbs are more affected especially the finger extensors.[16]
Less common symptoms
- Pelvic floor weakness
- The weakness of pelvic floor muscles leads to urinary incontinency especially during cough or strain.[18][19]
References
References
- β Alkhawajah NM, Oger J (November 2013). “Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing”. Muscle Nerve. 48 (5): 705β10. doi:10.1002/mus.23964. PMIDΒ 23893883.
- β Phillips LH, Torner JC, Anderson MS, Cox GM (October 1992). “The epidemiology of myasthenia gravis in central and western Virginia”. Neurology. 42 (10): 1888β93. PMIDΒ 1407568.
- β Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, Claussen GC (March 2009). “Racial differences in myasthenia gravis in Alabama”. Muscle Nerve. 39 (3): 328β32. doi:10.1002/mus.21191. PMCΒ 2814330. PMIDΒ 19127534.
- β Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (June 2003). “Clinical aspects of MuSK antibody positive seronegative MG”. Neurology. 60 (12): 1978β80. PMIDΒ 12821744.
- β 5.0 5.1 Osher RH, Glaser JS (March 1980). “Myasthenic sustained gaze fatigue”. Am. J. Ophthalmol. 89 (3): 443β5. PMIDΒ 7369304.
- β 6.0 6.1 Spooner JW, Baloh RW (January 1979). “Eye movement fatigue in myasthenia gravis”. Neurology. 29 (1): 29β33. PMIDΒ 570673.
- β 7.0 7.1 Lepore FE, Sanborn GE, Slevin JT (July 1979). “Pupillary dysfunction in myasthenia gravis”. Ann. Neurol. 6 (1): 29β33. doi:10.1002/ana.410060107. PMIDΒ 228589.
- β 8.0 8.1 Patten BM (1978). “Myasthenia gravis: review of diagnosis and management”. Muscle Nerve. 1 (3): 190β205. doi:10.1002/mus.880010304. PMIDΒ 86952.
- β 9.0 9.1 De Assis JL, Marchiori PE, Scaff M (1994). “Atrophy of the tongue with persistent articulation disorder in myasthenia gravis: report of 10 patients”. Auris Nasus Larynx. 21 (4): 215β8. PMIDΒ 7779022.
- β 10.0 10.1 Oosterhuis H, Bethlem J (April 1973). “Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study”. J. Neurol. Neurosurg. Psychiatry. 36 (2): 244β54. PMCΒ 1083560. PMIDΒ 4708458.
- β 11.0 11.1 Keesey JC (July 2002). ““Crisis” in myasthenia gravis: an historical perspective”. Muscle Nerve. 26 (1): 1β3. doi:10.1002/mus.10095. PMIDΒ 12115943.
- β 12.0 12.1 Keesey JC (November 1999). “Does myasthenia gravis affect the brain?”. J. Neurol. Sci. 170 (2): 77β89. PMIDΒ 10561522.
- β 13.0 13.1 Jablecki C, Benton A (1982). “The frequency of muscle involvement in myasthenia gravis correlates with mean muscle temperature”. Muscle Nerve. 5 (6): 491β2. PMIDΒ 6290881.
- β 14.0 14.1 Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN (June 1982). “A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel”. Ann. Neurol. 11 (6): 553β69. doi:10.1002/ana.410110603. PMIDΒ 6287911.
- β 15.0 15.1 Oh SJ, Kuruoglu R (June 1992). “Chronic limb-girdle myasthenia gravis”. Neurology. 42 (6): 1153β6. PMIDΒ 1603341.
- β 16.0 16.1 Nations SP, Wolfe GI, Amato AA, Jackson CE, Bryan WW, Barohn RJ (February 1999). “Distal myasthenia gravis”. Neurology. 52 (3): 632β4. PMIDΒ 10025802.
- β 17.0 17.1 Ochs CW, Bradley RJ, Katholi CR, Byl NN, Brown VM, Jones LL, Shohet JS (1998). “Symptoms of patients with myasthenia gravis receiving treatment”. J Med. 29 (1β2): 1β12. PMIDΒ 9704288.
- β 18.0 18.1 Greene LF, Ghosh MK, Howard FM (August 1974). “Transurethral prostatic resection in patients with myasthenia gravis”. J. Urol. 112 (2): 226β7. PMIDΒ 4843338.
- β 19.0 19.1 Wise GJ, Gerstenfeld JN, Brunner N, Grob D (August 1982). “Urinary incontinence following prostatectomy in patients with myasthenia gravis”. Br J Urol. 54 (4): 369β71. PMIDΒ 6180793.
- β 20.0 20.1 Silvestri NJ, Wolfe GI (July 2012). “Myasthenia gravis”. Semin Neurol. 32 (3): 215β26. doi:10.1055/s-0032-1329200. PMIDΒ 23117946.
- β 21.0 21.1 Keesey JC (April 2004). “Clinical evaluation and management of myasthenia gravis”. Muscle Nerve. 29 (4): 484β505. doi:10.1002/mus.20030. PMIDΒ 15052614.
- β 22.0 22.1 Keesey J, Buffkin D, Kebo D, Ho W, Herrmann C (1981). “Plasma exchange alone as therapy for myasthenia gravis”. Ann. N. Y. Acad. Sci. 377: 729β43. PMIDΒ 6951497.
- β Roberts ME, Steiger MJ, Hart IK (January 2002). “Presentation of myasthenia gravis mimicking blepharospasm”. Neurology. 58 (1): 150β1. PMIDΒ 11781428.
Looking for the patient version?
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
